<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">30948838</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1471-0048</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>20</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nature reviews. Neuroscience</Title>
          <ISOAbbreviation>Nat Rev Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Embracing diversity in the 5-HT neuronal system.</ArticleTitle>
        <Pagination>
          <StartPage>397</StartPage>
          <EndPage>424</EndPage>
          <MedlinePgn>397-424</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41583-019-0151-3</ELocationID>
        <Abstract>
          <AbstractText>Neurons that synthesize and release 5-hydroxytryptamine (5-HT; serotonin) express a core set of genes that establish and maintain this neurotransmitter phenotype and distinguish these neurons from other brain cells. Beyond a shared 5-HTergic phenotype, these neurons display divergent cellular properties in relation to anatomy, morphology, hodology, electrophysiology and gene expression, including differential expression of molecules supporting co-transmission of additional neurotransmitters. This diversity suggests that functionally heterogeneous subtypes of 5-HT neurons exist, but linking subsets of these neurons to particular functions has been technically challenging. We discuss recent data from molecular genetic, genomic and functional methods that, when coupled with classical findings, yield a reframing of the 5-HT neuronal system as a conglomeration of diverse subsystems with potential to inspire novel, more targeted therapies for clinically distinct 5-HT-related disorders.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Okaty</LastName>
            <ForeName>Benjamin W</ForeName>
            <Initials>BW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Genetics, Harvard Medical School, Boston, MA, USA. bokaty@genetics.med.harvard.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Commons</LastName>
            <ForeName>Kathryn G</ForeName>
            <Initials>KG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine Research, Children's Hospital Boston, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dymecki</LastName>
            <ForeName>Susan M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Genetics, Harvard Medical School, Boston, MA, USA. dymecki@genetics.med.harvard.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P01 HD036379</GrantID>
            <Acronym>HD</Acronym>
            <Agency>NICHD NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DA021801</GrantID>
            <Acronym>DA</Acronym>
            <Agency>NIDA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R21 DA023643</GrantID>
            <Acronym>DA</Acronym>
            <Agency>NIDA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nat Rev Neurosci</MedlineTA>
        <NlmUniqueID>100962781</NlmUniqueID>
        <ISSNLinking>1471-003X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>333DO1RDJY</RegistryNumber>
          <NameOfSubstance UI="D012701">Serotonin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059326" MajorTopicYN="N">Serotonergic Neurons</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012701" MajorTopicYN="N">Serotonin</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30948838</ArticleId>
        <ArticleId IdType="doi">10.1038/s41583-019-0151-3</ArticleId>
        <ArticleId IdType="pii">10.1038/s41583-019-0151-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Erspamer, V. &amp; Asero, B. Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature 169, 800–801 (1952). This paper is the first to recognize that enteramine and 5-HT are the same chemical.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14941051</ArticleId>
            <ArticleId IdType="doi">10.1038/169800b0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Twarog, B. M. &amp; Page, I. H. Serotonin content of some mammalian tissues and urine and a method for its determination. Am. J. Physiol. 175, 157–161 (1953). This paper is the first to demonstrate that 5-HT is present in vertebrate brain extracts.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13114371</ArticleId>
            <ArticleId IdType="doi">10.1152/ajplegacy.1953.175.1.157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vialli, M. &amp; Erspamer, V. Ricerche sul secreto delle cellule enterocromaffini. Z. Zellforsch. Mikrosk. Anat. 27, 81–99 (1937). This paper presents the first reported discovery of ‘enteramine’ (5-HT), a chemical that was isolated from enterochromaffin cells in the rabbit gut mucosa and was shown to possess smooth-muscle-contracting properties.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00391792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rapport, M. M., Green, A. A. &amp; Page, I. H. Crystalline serotonin. Science 108, 329–330 (1948). This paper presents the first reported discovery of 5-HT, which was isolated from beef serum and shown to act as a vasoconstrictor.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17748034</ArticleId>
            <ArticleId IdType="doi">10.1126/science.108.2804.329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rapport, M. M. Serum vasoconstrictor (serotonin) the presence of creatinine in the complex; a proposed structure of the vasoconstrictor principle. J. Biol. Chem. 180, 961–969 (1949). This paper is the first to describe the chemical structure of 5-HT.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18139191</ArticleId>
            <ArticleId IdType="doi">10.1016/S0021-9258(19)51208-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halliday, G. M. et al. Distribution of monoamine-synthesizing neurons in the human medulla oblongata. J. Comp. Neurol. 273, 301–317 (1988). This article presents the first immunohistological characterization of 5-HT neurons in the human medulla.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2905364</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.902730303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baker, K. G., Halliday, G. M. &amp; Tork, I. Cytoarchitecture of the human dorsal raphe nucleus. J. Comp. Neurol. 301, 147–161 (1990). This paper presents one of the first immunohistological characterizations of 5-HT neurons in the human DR.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2262589</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.903010202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baker, K. G. et al. Cytoarchitecture of serotonin-synthesizing neurons in the pontine tegmentum of the human brain. Synapse 7, 301–320 (1991). This article presents one of the first immunohistological characterizations of 5-HT neurons in the human MR.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2042112</ArticleId>
            <ArticleId IdType="doi">10.1002/syn.890070407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishimura, K. et al. Quantitative analysis of the distribution of serotonin-immunoreactive cell bodies in the mouse brain. Neurosci. Lett. 91, 265–270 (1988).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3185964</ArticleId>
            <ArticleId IdType="doi">10.1016/0304-3940(88)90691-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobs, B. L. &amp; Azmitia, E. C. Structure and function aof the brain serotonin system. Physiol. Rev. 72, 165–229 (1992).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1731370</ArticleId>
            <ArticleId IdType="doi">10.1152/physrev.1992.72.1.165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calizo, L. H. et al. Raphe serotonin neurons are not homogenous: electrophysiological, morphological and neurochemical evidence. Neuropharmacology 61, 524–543 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21530552</ArticleId>
            <ArticleId IdType="pmc">3120045</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuropharm.2011.04.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaspar, P. &amp; Lillesaar, C. Probing the diversity of serotonin neurons. Phil. Trans. R. Soc. B 367, 2382–2394 (2012).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22826339</ArticleId>
            <ArticleId IdType="doi">10.1098/rstb.2011.0378</ArticleId>
            <ArticleId IdType="pmc">3405676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrade, R. &amp; Haj-Dahmane, S. Serotonin neuron diversity in the dorsal raphe. ACS Chem. Neurosci. 4, 22–25 (2013).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23336040</ArticleId>
            <ArticleId IdType="pmc">3547477</ArticleId>
            <ArticleId IdType="doi">10.1021/cn300224n</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowry, C. A. Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J. Neuroendocrinol. 14, 911–923 (2002). This influential perspective article hypothesizes the existence of topographically organized functionally distinct 5-HT subsystems.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12421345</ArticleId>
            <ArticleId IdType="doi">10.1046/j.1365-2826.2002.00861.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hale, M. W. &amp; Lowry, C. A. Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits. Psychopharmacology 213, 243–264 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21088958</ArticleId>
            <ArticleId IdType="doi">10.1007/s00213-010-2089-z</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tork, I. Anatomy of the serotonergic system. Ann. NY Acad. Sci. 600, 9–34; discussion 34–35 (1990).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2252340</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1749-6632.1990.tb16870.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hannon, J. &amp; Hoyer, D. Molecular biology of 5-HT receptors. Behav. Brain Res. 195, 198–213 (2008).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18571247</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbr.2008.03.020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoyer, D. 5-HT receptor nomenclature: naming names, does it matter? A tribute to Maurice Rapport. ACS Chem. Neurosci. 8, 908–919 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28269984</ArticleId>
            <ArticleId IdType="doi">10.1021/acschemneuro.7b00011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Filip, M. &amp; Bader, M. Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol. Rep. 61, 761–777 (2009).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19903999</ArticleId>
            <ArticleId IdType="doi">10.1016/S1734-1140(09)70132-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dahlstroem, A. &amp; Fuxe, K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. Suppl. 232, S231–S255 (1964). This paper is the first characterization of the distribution of 5-HT in cell bodies of the rodent brainstem, and classification of 5-HT neurons into nine distinct anatomical clusters, using the Falck–Hillarp histochemical fluorescence technique.</Citation>
        </Reference>
        <Reference>
          <Citation>Alonso, A. et al. Development of the serotonergic cells in murine raphe nuclei and their relations with rhombomeric domains. Brain Struct. Funct. 218, 1229–1277 (2013). This paper proposes the most detailed anatomical subclassification of 5-HT neurons yet described, based in part on the inferred relationship between developmental rhombomeres and mature hindbrain anatomy.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23052546</ArticleId>
            <ArticleId IdType="doi">10.1007/s00429-012-0456-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jensen, P. et al. Redefining the serotonergic system by genetic lineage. Nat. Neurosci. 11, 417–419 (2008). This paper is the first to iteratively apply intersectional genetics to fate map mouse 5-HT neurons arising from different rhombomerically defined lineages, demonstrating distinct but in some cases overlapping anatomical distributions in the mature brainstem. This paper also introduces the Pet1–Flpe driver line, allowing genetic access to 5-HT neurons, compatible with the use of Cre lines.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18344997</ArticleId>
            <ArticleId IdType="pmc">2897136</ArticleId>
            <ArticleId IdType="doi">10.1038/nn2050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hornung, J. P. The human raphe nuclei and the serotonergic system. J. Chem. Neuroanat. 26, 331–343 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14729135</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jchemneu.2003.10.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baker, K. G. et al. Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus. Neuroscience 42, 757–775 (1991).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1720227</ArticleId>
            <ArticleId IdType="doi">10.1016/0306-4522(91)90043-N</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinbusch, H. W. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 6, 557–618 (1981). This article is the first comprehensive characterization of the rat 5-HT neuron system using serotonin immunohistology.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7017455</ArticleId>
            <ArticleId IdType="doi">10.1016/0306-4522(81)90146-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lidov, H. G. &amp; Molliver, M. E. Immunohistochemical study of the development of serotonergic neurons in the rat CNS. Brain Res. Bull. 9, 559–604 (1982).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6756556</ArticleId>
            <ArticleId IdType="doi">10.1016/0361-9230(82)90164-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newton, B. W., Maley, B. &amp; Traurig, H. The distribution of substance P, enkephalin, and serotonin immunoreactivities in the area postrema of the rat and cat. J. Comp. Neurol. 234, 87–104 (1985).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2579986</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.902340107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lanca, A. J. &amp; van der Kooy, D. A serotonin-containing pathway from the area postrema to the parabrachial nucleus in the rat. Neuroscience 14, 1117–1126 (1985).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2987755</ArticleId>
            <ArticleId IdType="doi">10.1016/0306-4522(85)90281-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller, R. L. &amp; Loewy, A. D. 5-HT neurons of the area postrema become c-Fos-activated after increases in plasma sodium levels and transmit interoceptive information to the nucleus accumbens. Am. J. Physiol. Regul. Integr. Comp. Physiol. 306, R663–R673 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24598462</ArticleId>
            <ArticleId IdType="pmc">4010663</ArticleId>
            <ArticleId IdType="doi">10.1152/ajpregu.00563.2013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azmitia, E. C. &amp; Gannon, P. J. The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. Adv. Neurol. 43, 407–468 (1986).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2418648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okaty, B. W. et al. Multi-scale molecular deconstruction of the serotonin neuron system. Neuron 88, 774–791 (2015). This study shows that molecular subtypes of 5-HT neurons identified by single-cell RNA-seq correspond to distinct rhombomerically defined sublineages and mature anatomical subdomains and show subtype-specific differences in electrophysiological properties, neuropeptide receptivity and in vivo behavioural functions, as revealed by conditional gene knockout and intersectional genetic neuron silencing experiments.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26549332</ArticleId>
            <ArticleId IdType="pmc">4809055</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2015.10.007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simon, H. H., Scholz, C. &amp; O’Leary, D. D. Engrailed genes control developmental fate of serotonergic and noradrenergic neurons in mid- and hindbrain in a gene dose-dependent manner. Mol. Cell Neurosci. 28, 96–105 (2005).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15607945</ArticleId>
            <ArticleId IdType="doi">10.1016/j.mcn.2004.08.016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Konig, N., Wilkie, M. B. &amp; Lauder, J. M. Tyrosine hydroxylase and serotonin containing cells in embryonic rat rhombencephalon: a whole-mount immunocytochemical study. J. Neurosci. Res. 20, 212–223 (1988).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2902232</ArticleId>
            <ArticleId IdType="doi">10.1002/jnr.490200210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aitken, A. R. &amp; Tork, I. Early development of serotonin-containing neurons and pathways as seen in wholemount preparations of the fetal rat brain. J. Comp. Neurol. 274, 32–47 (1988).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3047187</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.902740105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hennessy, M. L. et al. Activity of tachykinin1-expressing Pet1 raphe neurons modulates the respiratory chemoreflex. J. Neurosci. 37, 1807–1819 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28073937</ArticleId>
            <ArticleId IdType="pmc">5320611</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2316-16.2016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niederkofler, V. et al. Identification of serotonergic neuronal modules that affect aggressive behavior. Cell Rep. 17, 1934–1949 (2016). This paper applies intersectional genetic 5-HT neuron silencing to show that behavioural aggression, a behavioural function previously associated with the 5-HT system in general, can be modulated by small subsets of 5-HT neurons in the DR marked by intersectional expression of Pet1 and two different dopamine receptor genes, but not to others. This study also introduced a dual-recombinase-responsive synaptophysin–GFP ROSA26-knock-in mouse line for visualizing the synaptic terminals of intersectionally defined 5-HT neurons.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27851959</ArticleId>
            <ArticleId IdType="pmc">5156533</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2016.10.063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teissier, A. et al. Activity of raphe serotonergic neurons controls emotional behaviors. Cell Rep. 13, 1965–1976 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26655908</ArticleId>
            <ArticleId IdType="pmc">4756479</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2015.10.061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jensen, P. &amp; Dymecki, S. M. Essentials of recombinase-based genetic fate mapping in mice. Methods Mol. Biol. 1092, 437–454 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24318835</ArticleId>
            <ArticleId IdType="pmc">4035813</ArticleId>
            <ArticleId IdType="doi">10.1007/978-1-60327-292-6_26</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brust, R. D., Corcoran, A. E., Richerson, G. B., Nattie, E. &amp; Dymecki, S. M. Functional and developmental identification of a molecular subtype of brain serotonergic neuron specialized to regulate breathing dynamics. Cell Rep. 9, 2152–2165 (2014). This article presents the first study to use intersectional chemogenetics to study the in vivo physiological functions of rhombomerically defined subtypes of 5-HT neurons, demonstrating the importance of one particular subtype — r5 RMg–Pet1 neurons — in regulating the respiratory chemoreflex.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25497093</ArticleId>
            <ArticleId IdType="pmc">4351711</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.11.027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bang, S. J., Jensen, P., Dymecki, S. M. &amp; Commons, K. G. Projections and interconnections of genetically defined serotonin neurons in mice. Eur. J. Neurosci. 35, 85–96 (2012).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22151329</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1460-9568.2011.07936.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dymecki, S. M., Ray, R. S. &amp; Kim, J. C. Mapping cell fate and function using recombinase-based intersectional strategies. Methods Enzymol. 477, 183–213 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20699143</ArticleId>
            <ArticleId IdType="doi">10.1016/S0076-6879(10)77011-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sos, K. E. et al. Cellular architecture and transmitter phenotypes of neurons of the mouse median raphe region. Brain Struct. Funct. 222, 287–299 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27044051</ArticleId>
            <ArticleId IdType="doi">10.1007/s00429-016-1217-x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watson, C., Shimogori, T. &amp; Puelles, L. Mouse Fgf8-Cre-LacZ lineage analysis defines the territory of the postnatal mammalian isthmus. J. Comp. Neurol. 525, 2782–2799 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28510270</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.24242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frasch, M., Chen, X. &amp; Lufkin, T. Evolutionary-conserved enhancers direct region-specific expression of the murine Hoxa-1 and Hoxa-2 loci in both mice and Drosophila. Development 121, 957–974 (1995).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7743939</ArticleId>
            <ArticleId IdType="doi">10.1242/dev.121.4.957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Awatramani, R., Soriano, P., Rodriguez, C., Mai, J. J. &amp; Dymecki, S. M. Cryptic boundaries in roof plate and choroid plexus identified by intersectional gene activation. Nat. Genet. 35, 70–75 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12923530</ArticleId>
            <ArticleId IdType="doi">10.1038/ng1228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Bonito, M., Studer, M. &amp; Puelles, L. Nuclear derivatives and axonal projections originating from rhombomere 4 in the mouse hindbrain. Brain Struct. Funct. 222, 3509–3542 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28470551</ArticleId>
            <ArticleId IdType="pmc">5676809</ArticleId>
            <ArticleId IdType="doi">10.1007/s00429-017-1416-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walther, D. J. &amp; Bader, M. A unique central tryptophan hydroxylase isoform. Biochem. Pharmacol. 66, 1673–1680 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14563478</ArticleId>
            <ArticleId IdType="doi">10.1016/S0006-2952(03)00556-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walther, D. J. et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299, 76 (2003). This paper reports the discovery of a second isoform of the tryptophan hydroxylase gene, expressed exclusively in the CNS, and used by 5-HT neurons to synthesize 5-HT.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12511643</ArticleId>
            <ArticleId IdType="doi">10.1126/science.1078197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuntzman, R., Shore, P. A., Bogdanski, D. &amp; Brodie, B. B. Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain. J. Neurochem. 6, 226–232 (1961).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13755185</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1471-4159.1961.tb13469.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christenson, J. G., Dairman, W. &amp; Udenfriend, S. On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine). Proc. Natl Acad. Sci. USA 69, 343–347 (1972).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4536745</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.69.2.343</ArticleId>
            <ArticleId IdType="pmc">426454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albert, V. R., Allen, J. M. &amp; Joh, T. H. A single gene codes for aromatic L-amino acid decarboxylase in both neuronal and non-neuronal tissues. J. Biol. Chem. 262, 9404–9411 (1987).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3597416</ArticleId>
            <ArticleId IdType="doi">10.1016/S0021-9258(18)48094-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erickson, J. D., Schafer, M. K., Bonner, T. I., Eiden, L. E. &amp; Weihe, E. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc. Natl Acad. Sci. USA 93, 5166–5171 (1996).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8643547</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.93.10.5166</ArticleId>
            <ArticleId IdType="pmc">39426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weihe, E., Schafer, M. K., Erickson, J. D. &amp; Eiden, L. E. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J. Mol. Neurosci. 5, 149–164 (1994).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7654518</ArticleId>
            <ArticleId IdType="doi">10.1007/BF02736730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fon, E. A. et al. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19, 1271–1283 (1997).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9427250</ArticleId>
            <ArticleId IdType="doi">10.1016/S0896-6273(00)80418-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lesch, K. P., Wolozin, B. L., Estler, H. C., Murphy, D. L. &amp; Riederer, P. Isolation of a cDNA encoding the human brain serotonin transporter. J. Neural Transm. Gen. Sect. 91, 67–72 (1993).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8452685</ArticleId>
            <ArticleId IdType="doi">10.1007/BF01244919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffman, B. J., Mezey, E. &amp; Brownstein, M. J. Cloning of a serotonin transporter affected by antidepressants. Science 254, 579–580 (1991).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1948036</ArticleId>
            <ArticleId IdType="doi">10.1126/science.1948036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu, X. et al. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J. Biol. Chem. 273, 32776–32786 (1998).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9830022</ArticleId>
            <ArticleId IdType="doi">10.1074/jbc.273.49.32776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baganz, N. L. et al. Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc. Natl Acad. Sci. USA 105, 18976–18981 (2008).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19033200</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.0800466105</ArticleId>
            <ArticleId IdType="pmc">2596260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou, M., Engel, K. &amp; Wang, J. Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochem. Pharmacol. 73, 147–154 (2007).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17046718</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bcp.2006.09.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Engel, K., Zhou, M. &amp; Wang, J. Identification and characterization of a novel monoamine transporter in the human brain. J. Biol. Chem. 279, 50042–50049 (2004).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15448143</ArticleId>
            <ArticleId IdType="doi">10.1074/jbc.M407913200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bogdanski, D. F., Weissbach, H. &amp; Udenfriend, S. The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain. J. Neurochem. 1, 272–278 (1957).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13429371</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1471-4159.1957.tb12082.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levitt, P., Pintar, J. E. &amp; Breakefield, X. O. Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc. Natl Acad. Sci. USA 79, 6385–6389 (1982).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6755469</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.79.20.6385</ArticleId>
            <ArticleId IdType="pmc">347126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richards, J. G., Saura, J., Ulrich, J. &amp; Da Prada, M. Molecular neuroanatomy of monoamine oxidases in human brainstem. Psychopharmacology 106, S21–S23 (1992).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1546134</ArticleId>
            <ArticleId IdType="doi">10.1007/BF02246228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luque, J. M., Kwan, S. W., Abell, C. W., Da Prada, M. &amp; Richards, J. G. Cellular expression of mRNAs encoding monoamine oxidases A and B in the rat central nervous system. J. Comp. Neurol. 363, 665–680 (1995).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8847423</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.903630410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saura, J., Kettler, R., Da Prada, M. &amp; Richards, J. G. Quantitative enzyme radioautography with 3H-Ro 41–1049 and 3H-Ro 19–6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. J. Neurosci. 12, 1977–1999 (1992).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1578281</ArticleId>
            <ArticleId IdType="pmc">6575899</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.12-05-01977.1992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vitalis, T. et al. Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse. J. Comp. Neurol. 442, 331–347 (2002).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11793338</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.10093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lebrand, C. et al. Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 17, 823–835 (1996).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8938116</ArticleId>
            <ArticleId IdType="doi">10.1016/S0896-6273(00)80215-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lebrand, C. et al. Transient developmental expression of monoamine transporters in the rodent forebrain. J. Comp. Neurol. 401, 506–524 (1998).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9826275</ArticleId>
            <ArticleId IdType="doi">10.1002/(SICI)1096-9861(19981130)401:4&lt;506::AID-CNE5&gt;3.0.CO;2-#</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen, X. et al. Disruption of transient serotonin accumulation by non-serotonin-producing neurons impairs cortical map development. Cell Rep. 10, 346–358 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25600870</ArticleId>
            <ArticleId IdType="pmc">4824665</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.12.033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansson, S. R., Mezey, E. &amp; Hoffman, B. J. Serotonin transporter messenger RNA in the developing rat brain: early expression in serotonergic neurons and transient expression in non-serotonergic neurons. Neuroscience 83, 1185–1201 (1998).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9502257</ArticleId>
            <ArticleId IdType="doi">10.1016/S0306-4522(97)00444-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spencer, W. C. &amp; Deneris, E. S. Regulatory mechanisms controlling maturation of serotonin neuron identity and function. Front. Cell Neurosci. 11, 215 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28769770</ArticleId>
            <ArticleId IdType="pmc">5515867</ArticleId>
            <ArticleId IdType="doi">10.3389/fncel.2017.00215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kiyasova, V. &amp; Gaspar, P. Development of raphe serotonin neurons from specification to guidance. Eur. J. Neurosci. 34, 1553–1562 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22103413</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1460-9568.2011.07910.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fyodorov, D., Nelson, T. &amp; Deneris, E. Pet-1, a novel ETS domain factor that can activate neuronal nAchR gene transcription. J. Neurobiol. 34, 151–163 (1998).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9468386</ArticleId>
            <ArticleId IdType="doi">10.1002/(SICI)1097-4695(19980205)34:2&lt;151::AID-NEU5&gt;3.0.CO;2-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hendricks, T., Francis, N., Fyodorov, D. &amp; Deneris, E. S. The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes. J. Neurosci. 19, 10348–10356 (1999). This paper reports the discovery that Pet1, a gene encoding an ETS transcription factor, is a marker of 5-HT neurons, expressed embryonically just prior to the onset of 5-HT production, and expressed throughout maturity.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10575032</ArticleId>
            <ArticleId IdType="pmc">6782418</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.19-23-10348.1999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hendricks, T. J. et al. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 37, 233–247 (2003). This article demonstrates that Pet1not only is a marker of 5-HT neurons but also is required for the differentiation of the majority of 5-HT neurons.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12546819</ArticleId>
            <ArticleId IdType="doi">10.1016/S0896-6273(02)01167-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu, C. et al. Pet-1 is required across different stages of life to regulate serotonergic function. Nat. Neurosci. 13, 1190–1198 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20818386</ArticleId>
            <ArticleId IdType="pmc">2947586</ArticleId>
            <ArticleId IdType="doi">10.1038/nn.2623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wyler, S. C., Donovan, L. J., Yeager, M. &amp; Deneris, E. Pet-1 controls tetrahydrobiopterin pathway and Slc22a3 transporter genes in serotonin neurons. ACS Chem. Neurosci. 6, 1198–1205 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25642596</ArticleId>
            <ArticleId IdType="doi">10.1021/cn500331z</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iyo, A. H., Porter, B., Deneris, E. S. &amp; Austin, M. C. Regional distribution and cellular localization of the ETS-domain transcription factor, FEV, mRNA in the human postmortem brain. Synapse 57, 223–228 (2005).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15986391</ArticleId>
            <ArticleId IdType="pmc">2923919</ArticleId>
            <ArticleId IdType="doi">10.1002/syn.20178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pelosi, B., Migliarini, S., Pacini, G., Pratelli, M. &amp; Pasqualetti, M. Generation of Pet1210-Cre transgenic mouse line reveals non-serotonergic expression domains of Pet1 both in CNS and periphery. PLOS ONE 9, e104318 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25098329</ArticleId>
            <ArticleId IdType="pmc">4123907</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0104318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barrett, K. T. et al. Partial raphe dysfunction in neurotransmission is sufficient to increase mortality after anoxic exposures in mice at a critical period in postnatal development. J. Neurosci. 36, 3943–3953 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27053202</ArticleId>
            <ArticleId IdType="pmc">4821907</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1796-15.2016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haugas, M., Tikker, L., Achim, K., Salminen, M. &amp; Partanen, J. Gata2 and Gata3 regulate the differentiation of serotonergic and glutamatergic neuron subtypes of the dorsal raphe. Development 143, 4495–4508 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27789623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kiyasova, V. et al. A genetically defined morphologically and functionally unique subset of 5-HT neurons in the mouse raphe nuclei. J. Neurosci. 31, 2756–2768 (2011). This paper presents an anatomical and hodological characterization of a unique subset of 5-HT neurons that persist in the absence of Pet1 expression.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21414898</ArticleId>
            <ArticleId IdType="pmc">6623784</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4080-10.2011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding, Y. Q. et al. Lmx1b is essential for the development of serotonergic neurons. Nat. Neurosci. 6, 933–938 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12897786</ArticleId>
            <ArticleId IdType="doi">10.1038/nn1104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Craven, S. E. et al. Gata2 specifies serotonergic neurons downstream of sonic hedgehog. Development 131, 1165–1173 (2004).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14973276</ArticleId>
            <ArticleId IdType="doi">10.1242/dev.01024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao, Z. Q. et al. Lmx1b is required for maintenance of central serotonergic neurons and mice lacking central serotonergic system exhibit normal locomotor activity. J. Neurosci. 26, 12781–12788 (2006).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17151281</ArticleId>
            <ArticleId IdType="pmc">6674835</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4143-06.2006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan, R. et al. Lmx1b controls peptide phenotypes in serotonergic and dopaminergic neurons. Acta Biochim. Biophys. Sin. 45, 345–352 (2013).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23532063</ArticleId>
            <ArticleId IdType="doi">10.1093/abbs/gmt023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott, M. M. et al. A genetic approach to access serotonin neurons for in vivo and in vitro studies. Proc. Natl Acad. Sci. USA 102, 16472–16477 (2005). This paper describes the development of two Pet1–Cre driver mouse lines, allowing for genetic access to 5-HT neurons, either constitutively or in a tamoxifen-inducible manner.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16251278</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.0504510102</ArticleId>
            <ArticleId IdType="pmc">1283423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wyler, S. C. et al. Pet-1 switches transcriptional targets postnatally to regulate maturation of serotonin neuron excitability. J. Neurosci. 36, 1758–1774 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26843655</ArticleId>
            <ArticleId IdType="pmc">4737783</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.3798-15.2016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Domonkos, A. et al. Divergent in vivo activity of non-serotonergic and serotonergic VGluT3-neurones in the median raphe region. J. Physiol. 594, 3775–3790 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27028801</ArticleId>
            <ArticleId IdType="pmc">4929318</ArticleId>
            <ArticleId IdType="doi">10.1113/JP272036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dulcis, D., Jamshidi, P., Leutgeb, S. &amp; Spitzer, N. C. Neurotransmitter switching in the adult brain regulates behavior. Science 340, 449–453 (2013).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23620046</ArticleId>
            <ArticleId IdType="doi">10.1126/science.1234152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guemez-Gamboa, A., Xu, L., Meng, D. &amp; Spitzer, N. C. Non-cell-autonomous mechanism of activity-dependent neurotransmitter switching. Neuron 82, 1004–1016 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24908484</ArticleId>
            <ArticleId IdType="pmc">4072120</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2014.04.029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spitzer, N. C. Neurotransmitter switching? No surprise. Neuron 86, 1131–1144 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26050033</ArticleId>
            <ArticleId IdType="pmc">4458710</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2015.05.028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dulcis, D. et al. Neurotransmitter switching regulated by miRNAs controls changes in social preference. Neuron 95, 1319–1333 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28867550</ArticleId>
            <ArticleId IdType="pmc">5893310</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2017.08.023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spitzer, N. C. Neurotransmitter switching in the developing and adult brain. Annu. Rev. Neurosci. 40, 1–19 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28301776</ArticleId>
            <ArticleId IdType="doi">10.1146/annurev-neuro-072116-031204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malek, Z. S., Sage, D., Pevet, P. &amp; Raison, S. Daily rhythm of tryptophan hydroxylase-2 messenger ribonucleic acid within raphe neurons is induced by corticoid daily surge and modulated by enhanced locomotor activity. Endocrinology 148, 5165–5172 (2007).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17595225</ArticleId>
            <ArticleId IdType="doi">10.1210/en.2007-0526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malek, Z. S., Pevet, P. &amp; Raison, S. Circadian change in tryptophan hydroxylase protein levels within the rat intergeniculate leaflets and raphe nuclei. Neuroscience 125, 749–758 (2004).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15099688</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2004.01.031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malek, Z. S., Dardente, H., Pevet, P. &amp; Raison, S. Tissue-specific expression of tryptophan hydroxylase mRNAs in the rat midbrain: anatomical evidence and daily profiles. Eur. J. Neurosci. 22, 895–901 (2005).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16115212</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1460-9568.2005.04264.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donner, N. C., Montoya, C. D., Lukkes, J. L. &amp; Lowry, C. A. Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression. Psychoneuroendocrinology 37, 645–661 (2012).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21924839</ArticleId>
            <ArticleId IdType="doi">10.1016/j.psyneuen.2011.08.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donner, N. &amp; Handa, R. J. Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience 163, 705–718 (2009).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19559077</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2009.06.046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hiroi, R. &amp; Handa, R. J. Estrogen receptor-beta regulates human tryptophan hydroxylase-2 through an estrogen response element in the 5’ untranslated region. J. Neurochem. 127, 487–495 (2013).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24033289</ArticleId>
            <ArticleId IdType="pmc">5825233</ArticleId>
            <ArticleId IdType="doi">10.1111/jnc.12401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Givan, S. A. &amp; Cummings, K. J. Intermittent severe hypoxia induces plasticity within serotonergic and catecholaminergic neurons in the neonatal rat ventrolateral medulla. J. Appl. Physiol. 120, 1277–1287 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26968026</ArticleId>
            <ArticleId IdType="doi">10.1152/japplphysiol.00048.2016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gardner, K. L. et al. Adverse experience during early life and adulthood interact to elevate tph2 mRNA expression in serotonergic neurons within the dorsal raphe nucleus. Neuroscience 163, 991–1001 (2009).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19647049</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2009.07.055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donner, N. C. et al. Elevated tph2 mRNA expression in a rat model of chronic anxiety. Depress. Anxiety 29, 307–319 (2012).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22511363</ArticleId>
            <ArticleId IdType="pmc">4414333</ArticleId>
            <ArticleId IdType="doi">10.1002/da.21925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lukkes, J. L., Kopelman, J. M., Donner, N. C., Hale, M. W. &amp; Lowry, C. A. Development x environment interactions control tph2 mRNA expression. Neuroscience 237, 139–150 (2013).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23403177</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2013.01.070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fox, J. H. et al. Preimmunization with a heat-killed preparation of Mycobacterium vaccae enhances fear extinction in the fear-potentiated startle paradigm. Brain Behav. Immun. 66, 70–84 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28888667</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbi.2017.08.014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Belin, M. F. et al. Immunohistochemical evidence for the presence of gamma-aminobutyric acid and serotonin in one nerve cell. A study on the raphe nuclei of the rat using antibodies to glutamate decarboxylase and serotonin. Brain Res. 275, 329–339 (1983).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6354359</ArticleId>
            <ArticleId IdType="doi">10.1016/0006-8993(83)90994-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johansson, O. et al. Immunohistochemical support for three putative transmitters in one neuron: coexistence of 5-hydroxytryptamine, substance P<sup>−</sup> and thyrotropin releasing hormone-like immunoreactivity in medullary neurons projecting to the spinal cord. Neuroscience 6, 1857–1881 (1981).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6170907</ArticleId>
            <ArticleId IdType="doi">10.1016/0306-4522(81)90028-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinbusch, H. W., Verhofstad, A. A. &amp; Joosten, H. W. Localization of serotonin in the central nervous system by immunohistochemistry: description of a specific and sensitive technique and some applications. Neuroscience 3, 811–819 (1978).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">362232</ArticleId>
            <ArticleId IdType="doi">10.1016/0306-4522(78)90033-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan-Palay, V. Evidence for the coexistence of serotonin and substance P in single raphe cells and fiber plexuses: combined immunocytochemistry and autoradiography. Adv. Exp. Med. Biol. 133, 81–97 (1981).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6172025</ArticleId>
            <ArticleId IdType="doi">10.1007/978-1-4684-3860-4_5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan-Palay, V., Jonsson, G. &amp; Palay, S. L. Serotonin and substance P coexist in neurons of the rat’s central nervous system. Proc. Natl Acad. Sci. USA 75, 1582–1586 (1978).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">274744</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.75.3.1582</ArticleId>
            <ArticleId IdType="pmc">411518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wylie, C. J. et al. Distinct transcriptomes define rostral and caudal serotonin neurons. J. Neurosci. 30, 670–684 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20071532</ArticleId>
            <ArticleId IdType="pmc">3403750</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4656-09.2010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dougherty, J. D. et al. The disruption of Celf6, a gene identified by translational profiling of serotonergic neurons, results in autism-related behaviors. J. Neurosci. 33, 2732–2753 (2013).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23407934</ArticleId>
            <ArticleId IdType="pmc">3711589</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4762-12.2013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farago, A. F., Awatramani, R. B. &amp; Dymecki, S. M. Assembly of the brainstem cochlear nuclear complex is revealed by intersectional and subtractive genetic fate maps. Neuron 50, 205–218 (2006).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16630833</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2006.03.014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spaethling, J. M. et al. Serotonergic neuron regulation informed by in vivo single-cell transcriptomics. FASEB J. 28, 771–780 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24192459</ArticleId>
            <ArticleId IdType="pmc">3898651</ArticleId>
            <ArticleId IdType="doi">10.1096/fj.13-240267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Storm-Mathisen, J. et al. First visualization of glutamate and GABA in neurones by immunocytochemistry. Nature 301, 517–520 (1983).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6130475</ArticleId>
            <ArticleId IdType="doi">10.1038/301517a0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nicholas, A. P., Cuello, A. C., Goldstein, M. &amp; Hokfelt, T. Glutamate-like immunoreactivity in medulla oblongata catecholamine/substance P neurons. Neuroreport 1, 235–238 (1990).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1717041</ArticleId>
            <ArticleId IdType="doi">10.1097/00001756-199011000-00016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nicholas, A. P., Pieribone, V. A., Arvidsson, U. &amp; Hokfelt, T. Serotonin-, substance P<sup>−</sup> and glutamate/aspartate-like immunoreactivities in medullo-spinal pathways of rat and primate. Neuroscience 48, 545–559 (1992).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1376453</ArticleId>
            <ArticleId IdType="doi">10.1016/0306-4522(92)90401-M</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaneko, T., Akiyama, H., Nagatsu, I. &amp; Mizuno, N. Immunohistochemical demonstration of glutaminase in catecholaminergic and serotoninergic neurons of rat brain. Brain Res. 507, 151–154 (1990).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1967973</ArticleId>
            <ArticleId IdType="doi">10.1016/0006-8993(90)90535-J</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fremeau, R. T. Jr. et al. The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc. Natl Acad. Sci. USA 99, 14488–14493 (2002).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12388773</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.222546799</ArticleId>
            <ArticleId IdType="pmc">137910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gras, C. et al. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J. Neurosci. 22, 5442–5451 (2002).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12097496</ArticleId>
            <ArticleId IdType="pmc">6758212</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.22-13-05442.2002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ni, B., Rosteck, P. R. Jr., Nadi, N. S. &amp; Paul, S. M. Cloning and expression of a cDNA encoding a brain-specific Na(+)-dependent inorganic phosphate cotransporter. Proc. Natl Acad. Sci. USA 91, 5607–5611 (1994).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8202535</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.91.12.5607</ArticleId>
            <ArticleId IdType="pmc">44045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takamori, S., Rhee, J. S., Rosenmund, C. &amp; Jahn, R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407, 189–194 (2000).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11001057</ArticleId>
            <ArticleId IdType="doi">10.1038/35025070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takamori, S., Rhee, J. S., Rosenmund, C. &amp; Jahn, R. Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2). J. Neurosci. 21, RC182 (2001).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11698620</ArticleId>
            <ArticleId IdType="pmc">6762262</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.21-22-j0002.2001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herzog, E. et al. Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain. Neuroscience 123, 983–1002 (2004).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14751290</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2003.10.039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hioki, H. et al. Chemically specific circuit composed of vesicular glutamate transporter 3- and preprotachykinin B-producing interneurons in the rat neocortex. Cereb. Cortex 14, 1266–1275 (2004).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15142960</ArticleId>
            <ArticleId IdType="doi">10.1093/cercor/bhh088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hioki, H. et al. Vesicular glutamate transporter 3-expressing nonserotonergic projection neurons constitute a subregion in the rat midbrain raphe nuclei. J. Comp. Neurol. 518, 668–686 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20034056</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.22237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Commons, K. G. Locally collateralizing glutamate neurons in the dorsal raphe nucleus responsive to substance P contain vesicular glutamate transporter 3 (VGLUT3). J. Chem. Neuroanat. 38, 273–281 (2009).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19467322</ArticleId>
            <ArticleId IdType="pmc">2767471</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jchemneu.2009.05.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prouty, E. W., Chandler, D. J. &amp; Waterhouse, B. D. Neurochemical differences betweentarget-specific populations of rat dorsal raphe projection neurons. Brain Res. 1675, 28–40 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28867482</ArticleId>
            <ArticleId IdType="pmc">5822427</ArticleId>
            <ArticleId IdType="doi">10.1016/j.brainres.2017.08.031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grimes, W. N., Seal, R. P., Oesch, N., Edwards, R. H. &amp; Diamond, J. S. Genetic targeting and physiological features of VGLUT3+amacrine cells. Vis. Neurosci. 28, 381–392 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21864449</ArticleId>
            <ArticleId IdType="pmc">4150031</ArticleId>
            <ArticleId IdType="doi">10.1017/S0952523811000290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren, J. et al. Anatomically defined and functionally distinct dorsal raphe serotonin sub-systems. Cell 175, 472–487 (2018). This study shows that DR 5-HT neurons can be broadly subdivided into (partially overlapping) cortical-projecting and subcortical-projecting populations, with cell body distributions preferentially localized to ventral and dorsal DR, respectively. Furthermore, the authors use fibre photometry, chemogenetics and conditional gene knockout to demonstrate that these distinct DR 5-HT neuron subpopulations show opposite in vivo activity responses to aversive stimuli and differentially promote active coping versus anxiety-like behaviours.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30146164</ArticleId>
            <ArticleId IdType="pmc">6173627</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cell.2018.07.043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stornetta, R. L. et al. Coexpression of vesicular glutamate transporter-3 and gamma-aminobutyric acidergic markers in rat rostral medullary raphe and intermediolateral cell column. J. Comp. Neurol. 492, 477–494 (2005).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16228993</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.20742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakamura, K. et al. Identification of sympathetic premotor neurons in medullary raphe regions mediating fever and other thermoregulatory functions. J. Neurosci. 24, 5370–5380 (2004).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15190110</ArticleId>
            <ArticleId IdType="pmc">6729310</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1219-04.2004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samano, C., Cifuentes, F. &amp; Morales, M. A. Neurotransmitter segregation: functional and plastic implications. Prog. Neurobiol. 97, 277–287 (2012).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22531669</ArticleId>
            <ArticleId IdType="doi">10.1016/j.pneurobio.2012.04.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang, S. et al. Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons. Nat. Neurosci. 18, 386–392 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25664911</ArticleId>
            <ArticleId IdType="pmc">4340758</ArticleId>
            <ArticleId IdType="doi">10.1038/nn.3945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nusbaum, M. P., Blitz, D. M., Swensen, A. M., Wood, D. &amp; Marder, E. The roles of co-transmission in neural network modulation. Trends Neurosci. 24, 146–154 (2001).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11182454</ArticleId>
            <ArticleId IdType="doi">10.1016/S0166-2236(00)01723-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shutoh, F., Ina, A., Yoshida, S., Konno, J. &amp; Hisano, S. Two distinct subtypes of serotonergic fibers classified by co-expression with vesicular glutamate transporter 3 in rat forebrain. Neurosci. Lett. 432, 132–136 (2008).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18222609</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neulet.2007.12.050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Voisin, A. N. et al. Axonal segregation and role of the vesicular glutamate transporter VGLUT3 in serotonin neurons. Front. Neuroanat. 10, 39 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27147980</ArticleId>
            <ArticleId IdType="pmc">4828685</ArticleId>
            <ArticleId IdType="doi">10.3389/fnana.2016.00039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El Mestikawy, S., Wallen-Mackenzie, A., Fortin, G. M., Descarries, L. &amp; Trudeau, L. E. From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nat. Rev. Neurosci. 12, 204–216 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21415847</ArticleId>
            <ArticleId IdType="doi">10.1038/nrn2969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soiza-Reilly, M. &amp; Commons, K. G. Glutamatergic drive of the dorsal raphe nucleus. J. Chem. Neuroanat. 41, 247–255 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21550397</ArticleId>
            <ArticleId IdType="pmc">3150565</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jchemneu.2011.04.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gagnon, D. &amp; Parent, M. Distribution of VGLUT3 in highly collateralized axons from the rat dorsal raphe nucleus as revealed by single-neuron reconstructions. PLOS ONE 9, e87709 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24504335</ArticleId>
            <ArticleId IdType="pmc">3913638</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0087709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amilhon, B. et al. VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. J. Neurosci. 30, 2198–2210 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20147547</ArticleId>
            <ArticleId IdType="pmc">6634029</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.5196-09.2010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson, M. D. Synaptic glutamate release by postnatal rat serotonergic neurons in microculture. Neuron 12, 433–442 (1994). This paper is the first to show synaptic co-release of glutamate and 5-HT by 5-HT neurons in ex vivo microculture.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7906530</ArticleId>
            <ArticleId IdType="doi">10.1016/0896-6273(94)90283-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson, M. D. Electrophysiological and histochemical properties of postnatal rat serotonergic neurons in dissociated cell culture. Neuroscience 63, 775–787 (1994).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7898677</ArticleId>
            <ArticleId IdType="doi">10.1016/0306-4522(94)90522-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson, M. D. &amp; Yee, A. G. Ultrastructure of electrophysiologically-characterized synapses formed by serotonergic raphe neurons in culture. Neuroscience 67, 609–623 (1995).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7675190</ArticleId>
            <ArticleId IdType="doi">10.1016/0306-4522(95)00010-G</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varga, V. et al. Fast synaptic subcortical control of hippocampal circuits. Science 326, 449–453 (2009).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19833972</ArticleId>
            <ArticleId IdType="doi">10.1126/science.1178307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu, Z. et al. Dorsal raphe neurons signal reward through 5-HT and glutamate. Neuron 81, 1360–1374 (2014). This paper is the first to show synaptic co-release of glutamate and 5-HT by genetically targeted 5-HT neurons in vivo using optogenetics and to further show that some of the behavioural functions served by 5-HT neurons, such as signalling reward, depend on glutamate co-release, as demonstrated by conditional loss of Vglut3 in Pet1neurons.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24656254</ArticleId>
            <ArticleId IdType="pmc">4411946</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2014.02.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qi, J. et al. A glutamatergic reward input from the dorsal raphe to ventral tegmental area dopamine neurons. Nat. Commun. 5, 5390 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25388237</ArticleId>
            <ArticleId IdType="doi">10.1038/ncomms6390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McDevitt, R. A. et al. Serotonergic versus nonserotonergic dorsal raphe projection neurons: differential participation in reward circuitry. Cell Rep. 8, 1857–1869 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25242321</ArticleId>
            <ArticleId IdType="pmc">4181379</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.08.037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhuang, X., Masson, J., Gingrich, J. A., Rayport, S. &amp; Hen, R. Targeted gene expression in dopamine and serotonin neurons of the mouse brain. J. Neurosci. Methods 143, 27–32 (2005).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15763133</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jneumeth.2004.09.020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sengupta, A., Bocchio, M., Bannerman, D. M., Sharp, T. &amp; Capogna, M. Control of amygdala circuits by 5-HT neurons via 5-HT and glutamate cotransmission. J. Neurosci. 37, 1785–1796 (2017). This study reports stimulation frequency-dependent co-transmitter release from 5-HT neuron synaptic terminals in the basal amygdala, with glutamate being released at low optogenetic stimulation frequencies (≤1 Hz) and 5-HT being released at higher stimulation frequencies (10–20 Hz), suggesting that some 5-HT neurons can quickly switch their neurotransmitter output depending on activity.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28087766</ArticleId>
            <ArticleId IdType="pmc">5320609</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2238-16.2016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kapoor, V., Provost, A. C., Agarwal, P. &amp; Murthy, V. N. Activation of raphe nuclei triggers rapid and distinct effects on parallel olfactory bulb output channels. Nat. Neurosci. 19, 271–282 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26752161</ArticleId>
            <ArticleId IdType="pmc">4948943</ArticleId>
            <ArticleId IdType="doi">10.1038/nn.4219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao, S. et al. Cell type-specific channelrhodopsin-2 transgenic mice for optogenetic dissection of neural circuitry function. Nat. Methods 8, 745–752 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21985008</ArticleId>
            <ArticleId IdType="pmc">3191888</ArticleId>
            <ArticleId IdType="doi">10.1038/nmeth.1668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stornetta, R. L. &amp; Guyenet, P. G. Distribution of glutamic acid decarboxylase mRNA-containing neurons in rat medulla projecting to thoracic spinal cord in relation to monoaminergic brainstem neurons. J. Comp. Neurol. 407, 367–380 (1999).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10320217</ArticleId>
            <ArticleId IdType="doi">10.1002/(SICI)1096-9861(19990510)407:3&lt;367::AID-CNE5&gt;3.0.CO;2-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu, W. et al. Chemical neuroanatomy of the dorsal raphe nucleus and adjacent structures of the mouse brain. J. Comp. Neurol. 518, 3464–3494 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20589909</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.22407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez, S. P. et al. Multiscale single-cell analysis reveals unique phenotypes of raphe 5-HT neurons projecting to the forebrain. Brain Struct. Funct. 221, 4007–4025 (2016). This study combines retrograde projection mapping, slice electrophysiology and post-recording single-cell RT-PCR of DR and MR 5-HT neurons and finds consistent relationships between hodological, electrophysiological and molecular phenotypes, suggestive of functionally distinct 5-HT neuron subtypes.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26608830</ArticleId>
            <ArticleId IdType="doi">10.1007/s00429-015-1142-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shikanai, H. et al. Distinct neurochemical and functional properties of GAD67-containing 5-HT neurons in the rat dorsal raphe nucleus. J. Neurosci. 32, 14415–14426 (2012).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23055511</ArticleId>
            <ArticleId IdType="pmc">6622392</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.5929-11.2012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu, Y., Wang, W., Diez-Sampedro, A. &amp; Richerson, G. B. Nonvesicular inhibitory neurotransmission via reversal of the GABA transporter GAT-1. Neuron 56, 851–865 (2007).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18054861</ArticleId>
            <ArticleId IdType="pmc">2156040</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2007.10.021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tritsch, N. X., Ding, J. B. &amp; Sabatini, B. L. Dopaminergic neurons inhibit striatal output through non-canonical release of GABA. Nature 490, 262–266 (2012).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23034651</ArticleId>
            <ArticleId IdType="pmc">3944587</ArticleId>
            <ArticleId IdType="doi">10.1038/nature11466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiba, T. &amp; Masuko, S. Coexistence of varying combinations of neuropeptides with 5-hydroxytryptamine in neurons of the raphe pallidus et obscurus projecting to the spinal cord. Neurosci. Res. 7, 13–23 (1989).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2573020</ArticleId>
            <ArticleId IdType="doi">10.1016/0168-0102(89)90033-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Appel, N. M., Wessendorf, M. W. &amp; Elde, R. P. Thyrotropin-releasing hormone in spinal cord: coexistence with serotonin and with substance P in fibers and terminals apposing identified preganglionic sympathetic neurons. Brain Res. 415, 137–143 (1987).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2441808</ArticleId>
            <ArticleId IdType="doi">10.1016/0006-8993(87)90276-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hokfelt, T. et al. Multiple messengers in descending serotonin neurons: localization and functional implications. J. Chem. Neuroanat. 18, 75–86 (2000).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10708921</ArticleId>
            <ArticleId IdType="doi">10.1016/S0891-0618(99)00037-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Groenewegen, H. J., Ahlenius, S., Haber, S. N., Kowall, N. W. &amp; Nauta, W. J. Cytoarchitecture, fiber connections, and some histochemical aspects of the interpeduncular nucleus in the rat. J. Comp. Neurol. 249, 65–102 (1986).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2426312</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.902490107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowker, R. M., Westlund, K. N., Sullivan, M. C., Wilber, J. F. &amp; Coulter, J. D. Transmitters of the raphe-spinal complex: immunocytochemical studies. Peptides 3, 291–298 (1982).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6181491</ArticleId>
            <ArticleId IdType="doi">10.1016/0196-9781(82)90089-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowker, R. M., Steinbusch, H. W. &amp; Coulter, J. D. Serotonergic and peptidergic projections to the spinal cord demonstrated by a combined retrograde HRP histochemical and immunocytochemical staining method. Brain Res. 211, 412–417 (1981).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6165436</ArticleId>
            <ArticleId IdType="doi">10.1016/0006-8993(81)90965-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan-Palay, V. Combined immunocytochemistry and autoradiography after in vivo injections of monoclonal antibody to substance P and 3H-serotonin: Coexistence of two putative transmitters in single raphe cells and fiber plexuses. Anat. Embryol. 156, 241–254 (1979).</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00299625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan-Palay, V. The paratrigeminal nucleus. II. Identification and inter-relations of catecholamine axons, indoleamine axons, and substance P immunoreactive cells in the neuropil. J. Neurocytol. 7, 419–442 (1978).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">99496</ArticleId>
            <ArticleId IdType="doi">10.1007/BF01173989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kachidian, P., Poulat, P., Marlier, L. &amp; Privat, A. Immunohistochemical evidence for the coexistence of substance P, thyrotropin-releasing hormone, GABA, methionine-enkephalin, and leucin-enkephalin in the serotonergic neurons of the caudal raphe nuclei: a dual labeling in the rat. J. Neurosci. Res. 30, 521–530 (1991).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1724785</ArticleId>
            <ArticleId IdType="doi">10.1002/jnr.490300309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sergeyev, V., Hokfelt, T. &amp; Hurd, Y. Serotonin and substance P co-exist in dorsal raphe neurons of the human brain. Neuroreport 10, 3967–3970 (1999).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10716242</ArticleId>
            <ArticleId IdType="doi">10.1097/00001756-199912160-00044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bright, F. M., Byard, R. W., Vink, R. &amp; Paterson, D. S. Normative distribution of substance P and its tachykinin neurokinin-1 receptor in the medullary serotonergic network of the human infant during postnatal development. Brain Res. Bull. 137, 319–328 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29331576</ArticleId>
            <ArticleId IdType="doi">10.1016/j.brainresbull.2018.01.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rood, B. D. et al. Dorsal raphe serotonin neurons in mice: immature hyperexcitability transitions to adult state during first three postnatal weeks suggesting sensitive period for environmental perturbation. J. Neurosci. 34, 4809–4821 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24695701</ArticleId>
            <ArticleId IdType="pmc">3972713</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1498-13.2014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Challis, C. et al. Raphe GABAergic neurons mediate the acquisition of avoidance after social defeat. J. Neurosci. 33, 13978–13988 (2013).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23986235</ArticleId>
            <ArticleId IdType="pmc">3756748</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2383-13.2013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crawford, L. K., Craige, C. P. &amp; Beck, S. G. Increased intrinsic excitability of lateral wing serotonin neurons of the dorsal raphe: a mechanism for selective activation in stress circuits. J. Neurophysiol. 103, 2652–2663 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20237311</ArticleId>
            <ArticleId IdType="pmc">2867584</ArticleId>
            <ArticleId IdType="doi">10.1152/jn.01132.2009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beck, S. G., Pan, Y. Z., Akanwa, A. C. &amp; Kirby, L. G. Median and dorsal raphe neurons are not electrophysiologically identical. J. Neurophysiol. 91, 994–1005 (2004). This study is one of the earliest to show the electrophysiological diversity of 5-HT neurons using patch clamp recordings in acute brain slices.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14573555</ArticleId>
            <ArticleId IdType="doi">10.1152/jn.00744.2003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirby, L. G., Pernar, L., Valentino, R. J. &amp; Beck, S. G. Distinguishing characteristics of serotonin and non-serotonin-containing cells in the dorsal raphe nucleus: electrophysiological and immunohistochemical studies. Neuroscience 116, 669–683 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12573710</ArticleId>
            <ArticleId IdType="doi">10.1016/S0306-4522(02)00584-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Severson, C. A., Wang, W., Pieribone, V. A., Dohle, C. I. &amp; Richerson, G. B. Midbrain serotonergic neurons are central pH chemoreceptors. Nat. Neurosci. 6, 1139–1140 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14517544</ArticleId>
            <ArticleId IdType="doi">10.1038/nn1130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Washburn, C. P., Sirois, J. E., Talley, E. M., Guyenet, P. G. &amp; Bayliss, D. A. Serotonergic raphe neurons express TASK channel transcripts and a TASK-like pH- and halothane-sensitive K<sup>+</sup> conductance. J. Neurosci. 22, 1256–1265 (2002).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11850453</ArticleId>
            <ArticleId IdType="pmc">6757559</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.22-04-01256.2002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baccini, G., Mlinar, B., Audero, E., Gross, C. T. &amp; Corradetti, R. Impaired chemosensitivity of mouse dorsal raphe serotonergic neurons overexpressing serotonin 1A (Htr1a) receptors. PLOS ONE 7, e45072 (2012).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23028768</ArticleId>
            <ArticleId IdType="pmc">3441566</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0045072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mulkey, D. K. et al. TASK channels determine pH sensitivity in select respiratory neurons but do not contribute to central respiratory chemosensitivity. J. Neurosci. 27, 14049–14058 (2007).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18094244</ArticleId>
            <ArticleId IdType="pmc">6673518</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4254-07.2007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sargin, D., Oliver, D. K. &amp; Lambe, E. K. Chronic social isolation reduces 5-HT neuronal activity via upregulated SK3 calcium-activated potassium channels. eLife 5, e21416 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27874831</ArticleId>
            <ArticleId IdType="pmc">5119885</ArticleId>
            <ArticleId IdType="doi">10.7554/eLife.21416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tye, K. M. Neural circuit motifs in valence processing. Neuron 100, 436–452 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30359607</ArticleId>
            <ArticleId IdType="pmc">6590698</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2018.10.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winston, J. S., Gottfried, J. A., Kilner, J. M. &amp; Dolan, R. J. Integrated neural representations of odor intensity and affective valence in human amygdala. J. Neurosci. 25, 8903–8907 (2005).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16192380</ArticleId>
            <ArticleId IdType="pmc">6725588</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1569-05.2005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson, A. K. et al. Dissociated neural representations of intensity and valence in human olfaction. Nat. Neurosci. 6, 196–202 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12536208</ArticleId>
            <ArticleId IdType="doi">10.1038/nn1001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Descarries, L., Watkins, K. C., Garcia, S. &amp; Beaudet, A. The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. J. Comp. Neurol. 207, 239–254 (1982).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7107985</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.902070305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kohler, C. &amp; Steinbusch, H. Identification of serotonin and non-serotonin-containing neurons of the mid-brain raphe projecting to the entorhinal area and the hippocampal formation. A combined immunohistochemical and fluorescent retrograde tracing study in the rat brain. Neuroscience 7, 951–975 (1982).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7048127</ArticleId>
            <ArticleId IdType="doi">10.1016/0306-4522(82)90054-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu, R. J., Lambe, E. K. &amp; Aghajanian, G. K. Somatodendritic autoreceptor regulation of serotonergic neurons: dependence on L-tryptophan and tryptophan hydroxylase-activating kinases. Eur. J. Neurosci. 21, 945–958 (2005).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15787701</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1460-9568.2005.03930.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mlinar, B., Montalbano, A., Piszczek, L., Gross, C. &amp; Corradetti, R. Firing properties of genetically identified dorsal raphe serotonergic neurons in brain slices. Front. Cell Neurosci. 10, 195 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27536220</ArticleId>
            <ArticleId IdType="pmc">4971071</ArticleId>
            <ArticleId IdType="doi">10.3389/fncel.2016.00195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trulson, M. E. &amp; Trulson, V. M. Activity of nucleus raphe pallidus neurons across the sleep-waking cycle in freely moving cats. Brain Res. 237, 232–237 (1982).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7074357</ArticleId>
            <ArticleId IdType="doi">10.1016/0006-8993(82)90572-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trulson, M. E., Crisp, T. &amp; Trulson, V. M. Activity of serotonin-containing nucleus centralis superior (Raphe medianus) neurons in freely moving cats. Exp. Brain Res. 54, 33–44 (1984).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6698147</ArticleId>
            <ArticleId IdType="doi">10.1007/BF00235816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trulson, M. E., Preussler, D. W. &amp; Trulson, V. M. Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats. J. Pharmacol. Exp. Ther. 228, 94–102 (1984).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6694110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trulson, M. E. &amp; Jacobs, B. L. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res. 163, 135–150 (1979). This study is one of the earliest to record single-unit activity of neurons of the DR in an awake and freely behaving vertebrate, showing that the activity of putative 5-HT neurons correlated with the level of behavioural arousal.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">218676</ArticleId>
            <ArticleId IdType="doi">10.1016/0006-8993(79)90157-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rasmussen, K., Heym, J. &amp; Jacobs, B. L. Activity of serotonin-containing neurons in nucleus centralis superior of freely moving cats. Exp. Neurol. 83, 302–317 (1984).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6692870</ArticleId>
            <ArticleId IdType="doi">10.1016/S0014-4886(84)90100-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Auerbach, S., Fornal, C. &amp; Jacobs, B. L. Response of serotonin-containing neurons in nucleus raphe magnus to morphine, noxious stimuli, and periaqueductal gray stimulation in freely moving cats. Exp. Neurol. 88, 609–628 (1985).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3996512</ArticleId>
            <ArticleId IdType="doi">10.1016/0014-4886(85)90075-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fornal, C., Auerbach, S. &amp; Jacobs, B. L. Activity of serotonin-containing neurons in nucleus raphe magnus in freely moving cats. Exp. Neurol. 88, 590–608 (1985).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3996511</ArticleId>
            <ArticleId IdType="doi">10.1016/0014-4886(85)90074-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilkinson, L. O. &amp; Jacobs, B. L. Lack of response of serotonergic neurons in the dorsal raphe nucleus of freely moving cats to stressful stimuli. Exp. Neurol. 101, 445–457 (1988).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3416986</ArticleId>
            <ArticleId IdType="doi">10.1016/0014-4886(88)90055-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobs, B. L., Fornal, C. A. &amp; Wilkinson, L. O. Neurophysiological and neurochemical studies of brain serotonergic neurons in behaving animals. Ann. NY Acad. Sci. 600, 260–268; discussion 268–271 (1990).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2252314</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1749-6632.1990.tb16888.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veasey, S. C., Fornal, C. A., Metzler, C. W. &amp; Jacobs, B. L. Response of serotonergic caudal raphe neurons in relation to specific motor activities in freely moving cats. J. Neurosci. 15, 5346–5359 (1995).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7623157</ArticleId>
            <ArticleId IdType="pmc">6577863</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.15-07-05346.1995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobs, B. L., Martin-Cora, F. J. &amp; Fornal, C. A. Activity of medullary serotonergic neurons in freely moving animals. Brain Res. Brain Res. Rev. 40, 45–52 (2002).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12589905</ArticleId>
            <ArticleId IdType="doi">10.1016/S0165-0173(02)00187-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin-Cora, F. J., Fornal, C. A. &amp; Jacobs, B. L. Single-unit responses of serotonergic medullary raphe neurons to cardiovascular challenges in freely moving cats. Eur. J. Neurosci. 22, 3195–3204 (2005).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16367786</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1460-9568.2005.04519.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aghajanian, G. K., Rosecrans, J. A. &amp; Sheard, M. H. Serotonin: release in the forebrain by stimulation of midbrain raphe. Science 156, 402–403 (1967).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4886538</ArticleId>
            <ArticleId IdType="doi">10.1126/science.156.3773.402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aghajanian, G. K. &amp; Haigler, H. J. L-Tryptophan as a selective histochemical marker for serotonergic neurons in single-cell recording studies. Brain Res. 81, 364–372 (1974).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4373133</ArticleId>
            <ArticleId IdType="doi">10.1016/0006-8993(74)90954-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aghajanian, G. K. &amp; Vandermaelen, C. P. Intracellular recordings from serotonergic dorsal raphe neurons: pacemaker potentials and the effect of LSD. Brain Res. 238, 463–469 (1982).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6284300</ArticleId>
            <ArticleId IdType="doi">10.1016/0006-8993(82)90124-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aghajanian, G. K. &amp; Vandermaelen, C. P. Intracellular recording in vivo from serotonergic neurons in the rat dorsal raphe nucleus: methodological considerations. J. Histochem. Cytochem. 30, 813–814 (1982).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6749973</ArticleId>
            <ArticleId IdType="doi">10.1177/30.8.6749973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hajos, M., Gartside, S. E. &amp; Sharp, T. Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn Schmiedebergs Arch. Pharmacol. 351, 624–629 (1995).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7675121</ArticleId>
            <ArticleId IdType="doi">10.1007/BF00170162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharp, T., Umbers, V. &amp; Gartside, S. E. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br. J. Pharmacol. 121, 941–946 (1997).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9222551</ArticleId>
            <ArticleId IdType="pmc">1564780</ArticleId>
            <ArticleId IdType="doi">10.1038/sj.bjp.0701235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allers, K. A. &amp; Sharp, T. Neurochemical and anatomical identification of fast- and slow-firing neurones in the rat dorsal raphe nucleus using juxtacellular labelling methods in vivo. Neuroscience 122, 193–204 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14596860</ArticleId>
            <ArticleId IdType="doi">10.1016/S0306-4522(03)00518-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varga, V., Kocsis, B. &amp; Sharp, T. Electrophysiological evidence for convergence of inputs from the medial prefrontal cortex and lateral habenula on single neurons in the dorsal raphe nucleus. Eur. J. Neurosci. 17, 280–286 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12542664</ArticleId>
            <ArticleId IdType="doi">10.1046/j.1460-9568.2003.02465.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hajos, M. et al. Neurochemical identification of stereotypic burst-firing neurons in the rat dorsal raphe nucleus using juxtacellular labelling methods. Eur. J. Neurosci. 25, 119–126 (2007). This study is one of the first to demonstrate distinct subtypes of 5-HT neurons on the basis of in vivo firing properties.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17241273</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1460-9568.2006.05276.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen, J. Y., Amoroso, M. W. &amp; Uchida, N. Serotonergic neurons signal reward and punishment on multiple timescales. eLife 4, e06346 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">4389268</ArticleId>
            <ArticleId IdType="doi">10.7554/eLife.06346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kocsis, B., Varga, V., Dahan, L. &amp; Sik, A. Serotonergic neuron diversity: identification of raphe neurons with discharges time-locked to the hippocampal theta rhythm. Proc. Natl Acad. Sci. USA 103, 1059–1064 (2006).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16418294</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.0508360103</ArticleId>
            <ArticleId IdType="pmc">1347988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li, Y. et al. Serotonin neurons in the dorsal raphe nucleus encode reward signals. Nat. Commun. 7, 10503 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26818705</ArticleId>
            <ArticleId IdType="pmc">4738365</ArticleId>
            <ArticleId IdType="doi">10.1038/ncomms10503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matias, S., Lottem, E., Dugue, G. P. &amp; Mainen, Z. F. Activity patterns of serotonin neurons underlying cognitive flexibility. eLife 6, e20552 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28322190</ArticleId>
            <ArticleId IdType="pmc">5360447</ArticleId>
            <ArticleId IdType="doi">10.7554/eLife.20552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhong, W., Li, Y., Feng, Q. &amp; Luo, M. Learning and stress shape the reward response patterns of serotonin neurons. J. Neurosci. 37, 8863–8875 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28821671</ArticleId>
            <ArticleId IdType="pmc">6596795</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1181-17.2017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo, M., Li, Y. &amp; Zhong, W. Do dorsal raphe 5-HT neurons encode “beneficialness. Neurobiol. Learn. Mem. 135, 40–49 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27544850</ArticleId>
            <ArticleId IdType="doi">10.1016/j.nlm.2016.08.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azmitia, E. C. &amp; Segal, M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179, 641–667 (1978).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">565370</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.901790311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muzerelle, A., Scotto-Lomassese, S., Bernard, J. F., Soiza-Reilly, M. &amp; Gaspar, P. Conditional anterograde tracing reveals distinct targeting of individual serotonin cell groups (B5-B9) to the forebrain and brainstem. Brain Struct. Funct. 221, 535–561 (2016). This study employs conditional expression of anterogradely transported AAV virus encoding Cre-dependent GFP to comprehensively characterize the projection targets of separately transfected 5-HT (Sert–Cre) neuron subpopulations with cell bodies occupying distinct raphe nuclei. The authors demonstrate that 5-HT neurons residing in distinct nuclei mostly project to non-overlapping targets, arguing for topographic organization of 5-HT neuron efferent pathways.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25403254</ArticleId>
            <ArticleId IdType="doi">10.1007/s00429-014-0924-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kast, R. J., Wu, H. H., Williams, P., Gaspar, P. &amp; Levitt, P. Specific connectivity and unique molecular identity of MET receptor tyrosine kinase expressing serotonergic neurons in the caudal dorsal raphe nuclei. ACS Chem. Neurosci. 8, 1053–1064 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28375615</ArticleId>
            <ArticleId IdType="doi">10.1021/acschemneuro.7b00020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Descarries, L., Riad, M. &amp; Parent, M. Ultrastructure of the serotonin innervation in the mammalian central nervous system-CHAPTER 1.4. Handb. Behav. Neurosci. 21, 65–101 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1569-7339(10)70072-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moukhles, H. et al. Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra. Neuroscience 76, 1159–1171 (1997).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9027876</ArticleId>
            <ArticleId IdType="doi">10.1016/S0306-4522(96)00452-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dinopoulos, A., Dori, I. &amp; Parnavelas, J. G. Serotonergic innervation of the mature and developing lateral septum of the rat: a light and electron microscopic immunocytochemical analysis. Neuroscience 55, 209–222 (1993).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8350987</ArticleId>
            <ArticleId IdType="doi">10.1016/0306-4522(93)90467-T</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papadopoulos, G. C., Parnavelas, J. G. &amp; Buijs, R. M. Light and electron microscopic immunocytochemical analysis of the serotonin innervation of the rat visual cortex. J. Neurocytol. 16, 883–892 (1987).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3450795</ArticleId>
            <ArticleId IdType="doi">10.1007/BF01611992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muller, J. F., Mascagni, F. &amp; McDonald, A. J. Serotonin-immunoreactive axon terminals innervate pyramidal cells and interneurons in the rat basolateral amygdala. J. Comp. Neurol. 505, 314–335 (2007).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17879281</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.21486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ridet, J. L., Rajaofetra, N., Teilhac, J. R., Geffard, M. &amp; Privat, A. Evidence for nonsynaptic serotonergic and noradrenergic innervation of the rat dorsal horn and possible involvement of neuron-glia interactions. Neuroscience 52, 143–157 (1993).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8381923</ArticleId>
            <ArticleId IdType="doi">10.1016/0306-4522(93)90189-M</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bunin, M. A. &amp; Wightman, R. M. Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission. J. Neurosci. 18, 4854–4860 (1998).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9634551</ArticleId>
            <ArticleId IdType="pmc">6792557</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.18-13-04854.1998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bunin, M. A. &amp; Wightman, R. M. Paracrine neurotransmission in the CNS: involvement of 5-HT. Trends Neurosci. 22, 377–382 (1999).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10441294</ArticleId>
            <ArticleId IdType="doi">10.1016/S0166-2236(99)01410-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agnati, L. F. et al. A correlation analysis of the regional distribution of central enkephalin and beta-endorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: the volume transmission and the wiring transmission. Acta Physiol. Scand. 128, 201–207 (1986).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3022556</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1748-1716.1986.tb07967.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fuxe, K. et al. From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission. Brain Res. Rev. 55, 17–54 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainresrev.2007.02.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mlinar, B. et al. Nonexocytotic serotonin release tonically suppresses serotonergic neuron activity. J. Gen. Physiol. 145, 225–251 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25712017</ArticleId>
            <ArticleId IdType="pmc">4338157</ArticleId>
            <ArticleId IdType="doi">10.1085/jgp.201411330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colgan, L. A., Cavolo, S. L., Commons, K. G. &amp; Levitan, E. S. Action potential-independent and pharmacologically unique vesicular serotonin release from dendrites. J. Neurosci. 32, 15737–15746 (2012).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23136413</ArticleId>
            <ArticleId IdType="pmc">3505755</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.0020-12.2012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eulenburg, V. &amp; Gomeza, J. Neurotransmitter transporters expressed in glial cells as regulators of synapse function. Brain Res. Rev. 63, 103–112 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20097227</ArticleId>
            <ArticleId IdType="doi">10.1016/j.brainresrev.2010.01.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hrdina, P. D., Foy, B., Hepner, A. &amp; Summers, R. J. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter. J. Pharmacol. Exp. Ther. 252, 410–418 (1990).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2137177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sur, C., Betz, H. &amp; Schloss, P. Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience 73, 217–231 (1996).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8783244</ArticleId>
            <ArticleId IdType="doi">10.1016/0306-4522(96)00030-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown, P. &amp; Molliver, M. E. Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J. Neurosci. 20, 1952–1963 (2000).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10684896</ArticleId>
            <ArticleId IdType="pmc">6772942</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.20-05-01952.2000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kosofsky, B. E. &amp; Molliver, M. E. The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse 1, 153–168 (1987).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2463687</ArticleId>
            <ArticleId IdType="doi">10.1002/syn.890010204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mamounas, L. A. &amp; Molliver, M. E. Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Exp. Neurol. 102, 23–36 (1988).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2846339</ArticleId>
            <ArticleId IdType="doi">10.1016/0014-4886(88)90075-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molliver, M. E. Serotonergic neuronal systems: what their anatomic organization tells us about function. J. Clin. Psychopharmacol. 7, 3S–23S (1987).</Citation>
        </Reference>
        <Reference>
          <Citation>Mamounas, L. A., Mullen, C. A., O’Hearn, E. &amp; Molliver, M. E. Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. Comp. Neurol. 314, 558–586 (1991).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1814975</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.903140312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin, Y. et al. Regrowth of serotonin axons in the adult mouse brain following injury. Neuron 91, 748–762 (2016). Building off the work of Molliver and colleagues, this study uses in vivo two-photon microscopy in the neocortex of Sert–eYFP mice to study 5-HT neuron axon degeneration and subsequent regeneration over a period of months following exposure to amphetamine.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27499084</ArticleId>
            <ArticleId IdType="pmc">4990493</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2016.07.024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kajstura, T. J., Dougherty, S. E. &amp; Linden, D. J. Serotonin axons in the neocortex of the adult female mouse regrow after traumatic brain injury. J. Neurosci. Res. 96, 512–526 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28485037</ArticleId>
            <ArticleId IdType="pmc">5680161</ArticleId>
            <ArticleId IdType="doi">10.1002/jnr.24059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weissbourd, B. et al. Presynaptic partners of dorsal raphe serotonergic and GABAergic neurons. Neuron 83, 645–662 (2014). This is one of three concurrently released articles applying virally mediated monosynaptic retrograde circuit mapping to characterize brain-wide afferent inputs to 5-HT neurons of the rostral brainstem.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25102560</ArticleId>
            <ArticleId IdType="pmc">4779447</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2014.06.024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogawa, S. K., Cohen, J. Y., Hwang, D., Uchida, N. &amp; Watabe-Uchida, M. Organization of monosynaptic inputs to the serotonin and dopamine neuromodulatory systems. Cell Rep. 8, 1105–1118 (2014). This is one of three concurrently released articles applying virally mediated monosynaptic retrograde circuit mapping to characterize brain-wide afferent inputs to 5-HT neurons of the rostral brainstem.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25108805</ArticleId>
            <ArticleId IdType="pmc">4142108</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.06.042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pollak Dorocic, I. et al. A whole-brain atlas of inputs to serotonergic neurons of the dorsal and median raphe nuclei. Neuron 83, 663–678 (2014). This is one of three concurrently released articles applying virally mediated monosynaptic retrograde circuit mapping to characterize brain-wide afferent inputs to 5-HT neurons of the rostral brainstem.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25102561</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2014.07.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang, T. et al. ON and OFF retinal ganglion cells differentially regulate serotonergic and GABAergic activity in the dorsal raphe nucleus. Sci. Rep. 6, 26060 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27181078</ArticleId>
            <ArticleId IdType="pmc">4867631</ArticleId>
            <ArticleId IdType="doi">10.1038/srep26060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Commons, K. G. Two major network domains in the dorsal raphe nucleus. J. Comp. Neurol. 523, 1488–1504 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25652113</ArticleId>
            <ArticleId IdType="pmc">4439335</ArticleId>
            <ArticleId IdType="doi">10.1002/cne.23748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Commons, K. G. Ascending serotonin neuron diversity under two umbrellas. Brain Struct. Funct. 221, 3347–3360 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26740230</ArticleId>
            <ArticleId IdType="pmc">4935641</ArticleId>
            <ArticleId IdType="doi">10.1007/s00429-015-1176-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou, L. et al. Organization of functional long-range circuits controlling the activity of serotonergic neurons in the dorsal raphe nucleus. Cell Rep. 18, 3018–3032 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28329692</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2017.02.077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirby, L. G., Rice, K. C. &amp; Valentino, R. J. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22, 148–162 (2000).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10649828</ArticleId>
            <ArticleId IdType="doi">10.1016/S0893-133X(99)00093-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Audero, E. et al. Suppression of serotonin neuron firing increases aggression in mice. J. Neurosci. 33, 8678–8688 (2013).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23678112</ArticleId>
            <ArticleId IdType="pmc">6618819</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2067-12.2013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espallergues, J. et al. HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience. J. Neurosci. 32, 4400–4416 (2012).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22457490</ArticleId>
            <ArticleId IdType="pmc">3355377</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.5634-11.2012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richardson-Jones, J. W. et al. Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J. Neurosci. 31, 6008–6018 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21508226</ArticleId>
            <ArticleId IdType="pmc">3102496</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.5836-10.2011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ray, R. S. et al. Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition. Science 333, 637–642 (2011). This is the first published study to use chemogenetics to study the in vivo functions of 5-HT neurons.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21798952</ArticleId>
            <ArticleId IdType="pmc">3729433</ArticleId>
            <ArticleId IdType="doi">10.1126/science.1205295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muller, J. M., Morelli, E., Ansorge, M. &amp; Gingrich, J. A. Serotonin transporter deficient mice are vulnerable to escape deficits following inescapable shocks. Genes Brain Behav. 10, 166–175 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20955517</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1601-183X.2010.00652.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cummings, K. J., Hewitt, J. C., Li, A., Daubenspeck, J. A. &amp; Nattie, E. E. Postnatal loss of brainstem serotonin neurones compromises the ability of neonatal rats to survive episodic severe hypoxia. J. Physiol. 589, 5247–5256 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21911619</ArticleId>
            <ArticleId IdType="pmc">3225677</ArticleId>
            <ArticleId IdType="doi">10.1113/jphysiol.2011.214445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richardson-Jones, J. W. et al. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 65, 40–52 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20152112</ArticleId>
            <ArticleId IdType="pmc">2941196</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2009.12.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cummings, K. J., Li, A., Deneris, E. S. &amp; Nattie, E. E. Bradycardia in serotonin-deficient Pet-1<sup>−/−</sup> mice: influence of respiratory dysfunction and hyperthermia over the first 2 postnatal weeks. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R1333–R1342 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20421636</ArticleId>
            <ArticleId IdType="pmc">2867523</ArticleId>
            <ArticleId IdType="doi">10.1152/ajpregu.00110.2010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hodges, M. R. et al. Defects in breathing and thermoregulation in mice with near-complete absence of central serotonin neurons. J. Neurosci. 28, 2495–2505 (2008).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18322094</ArticleId>
            <ArticleId IdType="pmc">6671195</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4729-07.2008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mosienko, V. et al. Life without brain serotonin: reevaluation of serotonin function with mice deficient in brain serotonin synthesis. Behav. Brain Res. 277, 78–88 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24928769</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbr.2014.06.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jennings, K. A. et al. Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J. Neurosci. 26, 8955–8964 (2006).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16943551</ArticleId>
            <ArticleId IdType="pmc">6675351</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.5356-05.2006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maddaloni, G. et al. Serotonin depletion causes valproate-responsive manic-like condition and increased hippocampal neuroplasticity that are reversed by stress. Sci. Rep. 8, 11847 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30087403</ArticleId>
            <ArticleId IdType="pmc">6081464</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-018-30291-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fischer, A. G. &amp; Ullsperger, M. An update on the role of serotonin and its interplay with dopamine for reward. Front. Hum. Neurosci. 11, 484 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29075184</ArticleId>
            <ArticleId IdType="pmc">5641585</ArticleId>
            <ArticleId IdType="doi">10.3389/fnhum.2017.00484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu, H. Reward and aversion. Annu. Rev. Neurosci. 39, 297–324 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27145915</ArticleId>
            <ArticleId IdType="doi">10.1146/annurev-neuro-070815-014106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teixeira, C. M. et al. Hippocampal 5-HT input regulates memory formation and Schaffer collateral excitation. Neuron 98, 992–1004 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29754752</ArticleId>
            <ArticleId IdType="pmc">6383566</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2018.04.030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walsh, J. J. et al. 5-HT release in nucleus accumbens rescues social deficits in mouse autism model. Nature 560, 589–594 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30089910</ArticleId>
            <ArticleId IdType="doi">10.1038/s41586-018-0416-4</ArticleId>
            <ArticleId IdType="pmc">8164568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dolen, G., Darvishzadeh, A., Huang, K. W. &amp; Malenka, R. C. Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature 501, 179–184 (2013).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24025838</ArticleId>
            <ArticleId IdType="pmc">4091761</ArticleId>
            <ArticleId IdType="doi">10.1038/nature12518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyazaki, K. W. et al. Optogenetic activation of dorsal raphe serotonin neurons enhances patience for future rewards. Curr. Biol. 24, 2033–2040 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25155504</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cub.2014.07.041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu, S., Das, G., Hueske, E. &amp; Tonegawa, S. Dorsal raphe serotonergic neurons control intertemporal choice under trade-off. Curr. Biol. 27, 3111–3119 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28988863</ArticleId>
            <ArticleId IdType="pmc">5691357</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cub.2017.09.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nectow, A. R. et al. Identification of a brainstem circuit controlling feeding. Cell 170, 429–442 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28753423</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cell.2017.06.045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez, S. P. et al. Constitutive and acquired serotonin deficiency alters memory and hippocampal synaptic plasticity. Neuropsychopharmacology 42, 512–523 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27461084</ArticleId>
            <ArticleId IdType="doi">10.1038/npp.2016.134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pobbe, R. L., Zangrossi, H. Jr., Blanchard, D. C. &amp; Blanchard, R. J. Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors. Eur. Neuropsychopharmacol. 21, 306–315 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20570114</ArticleId>
            <ArticleId IdType="doi">10.1016/j.euroneuro.2010.05.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McNaughton, N. &amp; Corr, P. J. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci. Biobehav Rev. 28, 285–305 (2004).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15225972</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2004.03.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Millan, M. J. The neurobiology and control of anxious states. Prog. Neurobiol. 70, 83–244 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12927745</ArticleId>
            <ArticleId IdType="doi">10.1016/S0301-0082(03)00087-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graeff, F. G. On serotonin and experimental anxiety. Psychopharmacology 163, 467–476 (2002).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12373447</ArticleId>
            <ArticleId IdType="doi">10.1007/s00213-002-1112-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blanchard, D. C., Griebel, G., Rodgers, R. J. &amp; Blanchard, R. J. Benzodiazepine and serotonergic modulation of antipredator and conspecific defense. Neurosci. Biobehav Rev. 22, 597–612 (1998).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9662722</ArticleId>
            <ArticleId IdType="doi">10.1016/S0149-7634(97)00054-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Commons, K. G., Cholanians, A. B., Babb, J. A. &amp; Ehlinger, D. G. The rodent forced swim test measures stress-coping strategy, not depression-like behavior. ACS Chem. Neurosci. 8, 955–960 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28287253</ArticleId>
            <ArticleId IdType="doi">10.1021/acschemneuro.7b00042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roche, M., Commons, K. G., Peoples, A. &amp; Valentino, R. J. Circuitry underlying regulation of the serotonergic system by swim stress. J. Neurosci. 23, 970–977 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12574426</ArticleId>
            <ArticleId IdType="pmc">6741925</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.23-03-00970.2003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim, J. C. et al. Linking genetically defined neurons to behavior through a broadly applicable silencing allele. Neuron 63, 305–315 (2009). This is the first study to develop an intersectional genetic strategy for investigating the in vivo behavioural functions of 5-HT neuron subtypes by restricting the expression of a synaptic-silencing effector transgene (a ROSA26 knock-in allele) to neuron subsets defined by the intersectional expression of two genes.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19679071</ArticleId>
            <ArticleId IdType="pmc">2814245</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2009.07.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S. &amp; Roth, B. L. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc. Natl Acad. Sci. USA 104, 5163–5168 (2007).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17360345</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.0700293104</ArticleId>
            <ArticleId IdType="pmc">1829280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ansorge, M. S., Zhou, M., Lira, A., Hen, R. &amp; Gingrich, J. A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306, 879–881 (2004).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15514160</ArticleId>
            <ArticleId IdType="doi">10.1126/science.1101678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim, Y. et al. Whole-brain mapping of neuronal activity in the learned helplessness model of depression. Front. Neural Circuits 10, 3 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26869888</ArticleId>
            <ArticleId IdType="pmc">4737884</ArticleId>
            <ArticleId IdType="doi">10.3389/fncir.2016.00003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meloni, E. G., Reedy, C. L., Cohen, B. M. &amp; Carlezon, W. A. Jr. Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior. Biol. Psychiatry 63, 832–839 (2008).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18061145</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopsych.2007.10.016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson, P., Lowry, C., Truitt, W. &amp; Shekhar, A. Disruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic. J. Psychopharmacol. 22, 642–652 (2008).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18308791</ArticleId>
            <ArticleId IdType="pmc">3065198</ArticleId>
            <ArticleId IdType="doi">10.1177/0269881107082900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takase, L. F. et al. Inescapable shock activates serotonergic neurons in all raphe nuclei of rat. Behav. Brain Res. 153, 233–239 (2004).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15219724</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbr.2003.12.020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grahn, R. E. et al. Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor. Brain Res. 826, 35–43 (1999).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10216194</ArticleId>
            <ArticleId IdType="doi">10.1016/S0006-8993(99)01208-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohmura, Y., Tanaka, K. F., Tsunematsu, T., Yamanaka, A. &amp; Yoshioka, M. Optogenetic activation of serotonergic neurons enhances anxiety-like behaviour in mice. Int. J. Neuropsychopharmacol. 17, 1777–1783 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24834486</ArticleId>
            <ArticleId IdType="doi">10.1017/S1461145714000637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrade, T. G., Zangrossi, H. Jr &amp; Graeff, F. G. The median raphe nucleus in anxiety revisited. J. Psychopharmacol. 27, 1107–1115 (2013).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23999409</ArticleId>
            <ArticleId IdType="doi">10.1177/0269881113499208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishitani, N. et al. Manipulation of dorsal raphe serotonergic neurons modulates active coping to inescapable stress and anxiety-related behaviors in mice and rats. Neuropsychopharmacology 44, 721–732 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30377380</ArticleId>
            <ArticleId IdType="pmc">6372597</ArticleId>
            <ArticleId IdType="doi">10.1038/s41386-018-0254-y</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Urban, D. J. et al. Elucidation of the behavioral program and neuronal network encoded by dorsal raphe serotonergic neurons. Neuropsychopharmacology 41, 1404–1415 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26383016</ArticleId>
            <ArticleId IdType="doi">10.1038/npp.2015.293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marcinkiewcz, C. A. et al. Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala. Nature 537, 97–101 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27556938</ArticleId>
            <ArticleId IdType="pmc">5124365</ArticleId>
            <ArticleId IdType="doi">10.1038/nature19318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Correia, P. A. et al. Transient inhibition and long-term facilitation of locomotion by phasic optogenetic activation of serotonin neurons. eLife 6, e20975 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28193320</ArticleId>
            <ArticleId IdType="pmc">5308893</ArticleId>
            <ArticleId IdType="doi">10.7554/eLife.20975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chamberlain, B., Ervin, F. R., Pihl, R. O. &amp; Young, S. N. The effect of raising or lowering tryptophan levels on aggression in vervet monkeys. Pharmacol. Biochem. Behav. 28, 503–510 (1987).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3432316</ArticleId>
            <ArticleId IdType="doi">10.1016/0091-3057(87)90513-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mosienko, V. et al. Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin. Transl Psychiatry 2, e122 (2012).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22832966</ArticleId>
            <ArticleId IdType="pmc">3365263</ArticleId>
            <ArticleId IdType="doi">10.1038/tp.2012.44</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alenina, N. et al. Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc. Natl Acad. Sci. USA 106, 10332–10337 (2009).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19520831</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.0810793106</ArticleId>
            <ArticleId IdType="pmc">2700938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richerson, G. B. Response to CO2 of neurons in the rostral ventral medulla in vitro. J. Neurophysiol. 73, 933–944 (1995).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7608778</ArticleId>
            <ArticleId IdType="doi">10.1152/jn.1995.73.3.933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iceman, K. E., Richerson, G. B. &amp; Harris, M. B. Medullary serotonin neurons are CO<sub>2</sub> sensitive in situ. J. Neurophysiol. 110, 2536–2544 (2013).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24047906</ArticleId>
            <ArticleId IdType="pmc">3882770</ArticleId>
            <ArticleId IdType="doi">10.1152/jn.00288.2013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pilowsky, P. M., de Castro, D., Llewellyn-Smith, I., Lipski, J. &amp; Voss, M. D. Serotonin immunoreactive boutons make synapses with feline phrenic motoneurons. J. Neurosci. 10, 1091–1098 (1990).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2329370</ArticleId>
            <ArticleId IdType="pmc">6570230</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.10-04-01091.1990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Depuy, S. D., Kanbar, R., Coates, M. B., Stornetta, R. L. &amp; Guyenet, P. G. Control of breathing by raphe obscurus serotonergic neurons in mice. J. Neurosci. 31, 1981–1990 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21307236</ArticleId>
            <ArticleId IdType="pmc">3071248</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4639-10.2011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buchanan, G. F. &amp; Richerson, G. B. Central serotonin neurons are required for arousal to CO<sub>2</sub>. Proc. Natl Acad. Sci. USA 107, 16354–16359 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20805497</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1004587107</ArticleId>
            <ArticleId IdType="pmc">2941296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hodges, M. R., Wehner, M., Aungst, J., Smith, J. C. &amp; Richerson, G. B. Transgenic mice lacking serotonin neurons have severe apnea and high mortality during development. J. Neurosci. 29, 10341–10349 (2009).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19692608</ArticleId>
            <ArticleId IdType="pmc">2755228</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1963-09.2009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dosumu-Johnson, R. T., Cocoran, A. E., Chang, Y., Nattie, E. &amp; Dymecki, S. M. Acute perturbation of Pet1-neuron activity in neonatal mice impairs cardiorespiratory homeostatic recovery. eLife 7, e37857 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30350781</ArticleId>
            <ArticleId IdType="pmc">6199134</ArticleId>
            <ArticleId IdType="doi">10.7554/eLife.37857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donnelly, W. T., Xia, L., Bartlett, D. &amp; Leiter, J. C. Activation of serotonergic neurons in the medullary caudal raphe shortens the laryngeal chemoreflex in anaesthetized neonatal rats. Exp. Physiol. 102, 1007–1018 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28675564</ArticleId>
            <ArticleId IdType="doi">10.1113/EP086082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duncan, J. R. et al. Brainstem serotonergic deficiency in sudden infant death syndrome. JAMA 303, 430–437 (2010).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20124538</ArticleId>
            <ArticleId IdType="pmc">3242415</ArticleId>
            <ArticleId IdType="doi">10.1001/jama.2010.45</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paterson, D. S. et al. Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA 296, 2124–2132 (2006).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17077377</ArticleId>
            <ArticleId IdType="doi">10.1001/jama.296.17.2124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kinney, H. C. et al. Serotonergic brainstem abnormalities in Northern Plains Indians with the sudden infant death syndrome. J. Neuropathol. Exp. Neurol. 62, 1178–1191 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14656075</ArticleId>
            <ArticleId IdType="doi">10.1093/jnen/62.11.1178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bright, F. M., Byard, R. W., Vink, R. &amp; Paterson, D. S. Medullary serotonin neuron abnormalities in an Australian cohort of sudden infant death syndrome. J. Neuropathol. Exp. Neurol. 76, 864–873 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28922849</ArticleId>
            <ArticleId IdType="doi">10.1093/jnen/nlx071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu, Q. et al. Dopamine and serotonin signaling during two sensitive developmental periods differentially impact adult aggressive and affective behaviors in mice. Mol. Psychiatry 19, 688–698 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24589889</ArticleId>
            <ArticleId IdType="pmc">4311886</ArticleId>
            <ArticleId IdType="doi">10.1038/mp.2014.10</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olivier, B. Serotonergic mechanisms in aggression. Novartis Found. Symp. 268, 171–183 (2005).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16206880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graeff, F. G., Viana, M. B. &amp; Mora, P. O. Dual role of 5-HT in defense and anxiety. Neurosci. Biobehav Rev. 21, 791–799 (1997).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9415904</ArticleId>
            <ArticleId IdType="doi">10.1016/S0149-7634(96)00059-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blanchard, D. C., Sakai, R. R., McEwen, B., Weiss, S. M. &amp; Blanchard, R. J. Subordination stress: behavioral, brain, and neuroendocrine correlates. Behav. Brain Res. 58, 113–121 (1993).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8136039</ArticleId>
            <ArticleId IdType="doi">10.1016/0166-4328(93)90096-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raleigh, M. J., McGuire, M. T., Brammer, G. L., Pollack, D. B. &amp; Yuwiler, A. Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys. Brain Res. 559, 181–190 (1991).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1794096</ArticleId>
            <ArticleId IdType="doi">10.1016/0006-8993(91)90001-C</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rozeske, R. R. et al. Uncontrollable, but not controllable, stress desensitizes 5-HT1A receptors in the dorsal raphe nucleus. J. Neurosci. 31, 14107–14115 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21976495</ArticleId>
            <ArticleId IdType="pmc">3207271</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.3095-11.2011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maier, S. F. &amp; Watkins, L. R. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci. Biobehav Rev. 29, 829–841 (2005).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15893820</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2005.03.021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammack, S. E. et al. Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. J. Neurosci. 23, 1019–1025 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12574432</ArticleId>
            <ArticleId IdType="pmc">6741923</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.23-03-01019.2003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammack, S. E., Pepin, J. L., DesMarteau, J. S., Watkins, L. R. &amp; Maier, S. F. Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress. Behav. Brain Res. 147, 55–64 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14659570</ArticleId>
            <ArticleId IdType="doi">10.1016/S0166-4328(03)00133-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bland, S. T. et al. Stressor controllability modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux in the medial prefrontal cortex. Neuropsychopharmacology 28, 1589–1596 (2003).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12784102</ArticleId>
            <ArticleId IdType="doi">10.1038/sj.npp.1300206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammack, S. E. et al. The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress. J. Neurosci. 22, 1020–1026 (2002).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11826130</ArticleId>
            <ArticleId IdType="pmc">6758532</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.22-03-01020.2002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ettenberg, A. et al. Inactivation of the dorsal raphe nucleus reduces the anxiogenic response of rats running an alley for intravenous cocaine. Pharmacol. Biochem. Behav. 97, 632–639 (2011).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21108959</ArticleId>
            <ArticleId IdType="doi">10.1016/j.pbb.2010.11.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corrodi, H., Fuxe, K. &amp; Hokfelt, T. Central serotonin neurons and thermoregulation. Adv. Pharmacol. 6, 49–54 (1968).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5658332</ArticleId>
            <ArticleId IdType="doi">10.1016/S1054-3589(08)60294-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Magnusson, J. &amp; Cummings, K. J. Plasticity in breathing and arterial blood pressure following acute intermittent hypercapnic hypoxia in infant rat pups with a partial loss of 5-HT neurons. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309, R1273–R1284 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26354844</ArticleId>
            <ArticleId IdType="doi">10.1152/ajpregu.00241.2015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fonseca, M. S., Murakami, M. &amp; Mainen, Z. F. Activation of dorsal raphe serotonergic neurons promotes waiting but is not reinforcing. Curr. Biol. 25, 306–315 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25601545</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cub.2014.12.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lottem, E. et al. Activation of serotonin neurons promotes active persistence in a probabilistic foraging task. Nat. Commun. 9, 1000 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29520000</ArticleId>
            <ArticleId IdType="pmc">5843608</ArticleId>
            <ArticleId IdType="doi">10.1038/s41467-018-03438-y</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dugue, G. P. et al. Optogenetic recruitment of dorsal raphe serotonergic neurons acutely decreases mechanosensory responsivity in behaving mice. PLOS ONE 9, e105941 (2014).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25148042</ArticleId>
            <ArticleId IdType="pmc">4141837</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0105941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong-Lin, K., Wang, D. H., Moustafa, A. A., Cohen, J. Y. &amp; Nakamura, K. Toward a multiscale modeling framework for understanding serotonergic function. J. Psychopharmacol. 31, 1121–1136 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28417684</ArticleId>
            <ArticleId IdType="pmc">5606304</ArticleId>
            <ArticleId IdType="doi">10.1177/0269881117699612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tremblay, R., Lee, S. &amp; Rudy, B. GABAergic interneurons in the neocortex: from cellular properties to circuits. Neuron 91, 260–292 (2016).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27477017</ArticleId>
            <ArticleId IdType="pmc">4980915</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2016.06.033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Puissant, M. M., Mouradian, G. C. Jr., Liu, P. &amp; Hodges, M. R. Identifying candidate genes that underlie cellular pH sensitivity in serotonin neurons using transcriptomics: a potential role for Kir5.1 channels. Front. Cell Neurosci. 11, 34 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28270749</ArticleId>
            <ArticleId IdType="pmc">5318415</ArticleId>
            <ArticleId IdType="doi">10.3389/fncel.2017.00034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maddaloni, G. et al. Development of serotonergic fibers in the post-natal mouse brain. Front. Cell Neurosci. 11, 202 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28769763</ArticleId>
            <ArticleId IdType="pmc">5509955</ArticleId>
            <ArticleId IdType="doi">10.3389/fncel.2017.00202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deneris, E. &amp; Gaspar, P. Serotonin neuron development: shaping molecular and structural identities. Wiley Interdiscip. Rev. Dev. Biol. 7, e301 (2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/wdev.301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waddington, C. H. The Strategy of The Genes: A Discussion of Some Aspects of Theoretical Biology (Allen &amp; Unwin, 1957).</Citation>
        </Reference>
        <Reference>
          <Citation>Tononi, G., Sporns, O. &amp; Edelman, G. M. Measures of degeneracy and redundancy in biological networks. Proc. Natl Acad. Sci. USA 96, 3257–3262 (1999).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10077671</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.96.6.3257</ArticleId>
            <ArticleId IdType="pmc">15929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edelman, G. M. &amp; Gally, J. A. Degeneracy and complexity in biological systems. Proc. Natl Acad. Sci. USA 98, 13763–13768 (2001).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11698650</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.231499798</ArticleId>
            <ArticleId IdType="pmc">61115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weber, T. et al. Inducible gene manipulations in serotonergic neurons. Front. Mol. Neurosci. 2, 24 (2009).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19936315</ArticleId>
            <ArticleId IdType="pmc">2779094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gong, S. et al. Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. J. Neurosci. 27, 9817–9823 (2007).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17855595</ArticleId>
            <ArticleId IdType="pmc">6672645</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2707-07.2007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hainer, C. et al. Beyond gene inactivation: evolution of tools for analysis of serotonergic circuitry. ACS Chem. Neurosci. 6, 1116–1129 (2015).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26132472</ArticleId>
            <ArticleId IdType="doi">10.1021/acschemneuro.5b00045</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
